abstract |
A novel ophthalmic composition is provided. An ophthalmic composition comprises (A) one or more selected from the group consisting of tranilast and a salt thereof, (B) one or more selected from the group consisting of chlorpheniramine and a salt thereof, and (C ) Consists of one or more selected from the group consisting of pranoprofen and salts thereof. In such a composition, the ratio of the component (B) to 100 parts by mass of the component (A) may be 1 to 8 parts by mass, and the ratio of the component (C) may be 5 to 25 parts by mass. [Selection figure] None |